Nervous System Diseases

All Conditions

Symptoms and General Pathology

Peripheral Nervous System Diseases

Pain

Neuromuscular Diseases

Anticonvulsants

All Drugs and Chemicals

Ethosuximide

Drug will be dose escalated in order to reach maximum tolerated dose starting with 250mg.

Placebo

This study is a drug trial of ethosuximide as a painkiller if you develop pain as a side effect of chemotherapy. Ethosuximide will be compared against placebo (an inactive substance) to test whether any response is a true effect of the drug, and not a 'placebo effect'.

Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)

A Randomised Double-blind Placebo-controlled Trial of the Safety and Efficacy of Ethosuximide 250mg Capsules for the Management of Chemotherapy Induced Painful Peripheral Neuropathy

Imperial College London

Royal Marsden NHS Foundation Trust

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)	NCT01278004	Cancer Peripheral Neur...	Ethosuximide Placebo	18 Years -	Royal Marsden NHS Foundation Trust
Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)	NCT01278004	Cancer Peripheral Neur...	Ethosuximide Placebo	18 Years -	Royal Marsden NHS Foundation Trust
Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)	NCT01278004	Cancer Peripheral Neur...	Ethosuximide Placebo	18 Years -	Royal Marsden NHS Foundation Trust

Spots Global Cancer Trial Database for ethosuximide

Every month we try and update this database with for ethosuximide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.